Cargando…
Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine
Streptococcus pneumoniae is the leading cause of bacterial pneumonia. Although this is a vaccine preventable disease, S. pneumoniae still causes over 1 million deaths per year, mainly in children under the age of five. The biggest disease burden is in the developing world, which is mainly due to una...
Autores principales: | Herbert, Jenny A., Kay, Emily J., Faustini, Sian E., Richter, Alex, Abouelhadid, Sherif, Cuccui, Jon, Wren, Brendan, Mitchell, Timothy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999350/ https://www.ncbi.nlm.nih.gov/pubmed/29778517 http://dx.doi.org/10.1016/j.vaccine.2018.05.036 |
Ejemplares similares
-
Recombinant expression of Streptococcus pneumoniae capsular polysaccharides in Escherichia coli
por: Kay, Emily J., et al.
Publicado: (2016) -
Characterization of Posttranslationally Modified Multidrug Efflux Pumps Reveals an Unexpected Link between Glycosylation and Antimicrobial Resistance
por: Abouelhadid, Sherif, et al.
Publicado: (2020) -
Recent advances in the production of recombinant glycoconjugate vaccines
por: Kay, Emily, et al.
Publicado: (2019) -
Development of a novel glycoengineering platform for the rapid production of conjugate vaccines
por: Abouelhadid, Sherif, et al.
Publicado: (2023) -
Quantitative Analyses Reveal Novel Roles for N-Glycosylation in a Major Enteric Bacterial Pathogen
por: Abouelhadid, Sherif, et al.
Publicado: (2019)